NMPA Approval

Hemofiltration Basic Solution

Approval Number

国药准字H20183023

Company石家庄四药有限公司

Registration Date

February 2, 2018

Drug Information

Generic Name

血液滤过置换基础液

Dosage Form

注射剂

Strength

4000ml

Drug Type

化学药品

Registration Date

February 2, 2018

Company Information

Applicant Company

Company Name石家庄四药有限公司

Company Address

石家庄高新技术产业开发区槐安东路518号

Manufacturing Company

Company Name石家庄四药有限公司

Company Address

石家庄经济技术开发区扬子路；石家庄高新技术产业开发区槐安东路518号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

血液滤过置换基础液 - NMPA 批准文号 | MedPath